Text Size
1 study found for:    "NJMS" OR "New Jersey Medical School" | Open Studies | "Carcinoma, Non-Small-Cell Lung"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Adenocarcinoma of the Lung;   Bronchoalveolar Cell Lung Cancer;   Large Cell Lung Cancer;   Recurrent Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Interventions: Biological: cixutumumab;   Drug: paclitaxel;   Drug: carboplatin;   Biological: bevacizumab
To Top

† Indicates status has not been verified in more than two years